nodes	percent_of_prediction	percent_of_DWPC	metapath
Propranolol—CYP3A5—prostate cancer	0.102	0.279	CbGaD
Propranolol—ADRB2—prostate cancer	0.0806	0.221	CbGaD
Propranolol—CYP2C19—prostate cancer	0.0693	0.19	CbGaD
Propranolol—CYP1A1—prostate cancer	0.0691	0.189	CbGaD
Propranolol—ORM1—Abiraterone—prostate cancer	0.0459	0.107	CbGbCtD
Propranolol—CYP3A4—prostate cancer	0.0441	0.121	CbGaD
Propranolol—CYP1A1—Flutamide—prostate cancer	0.0258	0.0602	CbGbCtD
Propranolol—CYP1A1—Estrone—prostate cancer	0.0187	0.0435	CbGbCtD
Propranolol—SLC22A2—Estradiol—prostate cancer	0.0157	0.0367	CbGbCtD
Propranolol—CYP3A5—Flutamide—prostate cancer	0.0155	0.0361	CbGbCtD
Propranolol—CYP2C19—Nilutamide—prostate cancer	0.0151	0.0352	CbGbCtD
Propranolol—CYP2C19—Bicalutamide—prostate cancer	0.0151	0.0352	CbGbCtD
Propranolol—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0139	0.0324	CbGbCtD
Propranolol—CYP2C19—Flutamide—prostate cancer	0.0125	0.0291	CbGbCtD
Propranolol—CYP1A2—Flutamide—prostate cancer	0.0115	0.0269	CbGbCtD
Propranolol—CYP2D6—Bicalutamide—prostate cancer	0.0115	0.0267	CbGbCtD
Propranolol—CYP3A5—Cabazitaxel—prostate cancer	0.0115	0.0267	CbGbCtD
Propranolol—ABCB1—Estramustine—prostate cancer	0.0113	0.0264	CbGbCtD
Propranolol—CYP3A5—Estrone—prostate cancer	0.0112	0.0261	CbGbCtD
Propranolol—CYP1A1—Estradiol—prostate cancer	0.0107	0.025	CbGbCtD
Propranolol—CYP2D6—Abiraterone—prostate cancer	0.00951	0.0222	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Estradiol—prostate cancer	0.00858	0.02	CbGbCtD
Propranolol—CYP3A7—Estradiol—prostate cancer	0.00858	0.02	CbGbCtD
Propranolol—CYP1A2—Estrone—prostate cancer	0.00834	0.0194	CbGbCtD
Propranolol—ABCB1—Cabazitaxel—prostate cancer	0.00746	0.0174	CbGbCtD
Propranolol—CYP3A4—Bicalutamide—prostate cancer	0.0073	0.017	CbGbCtD
Propranolol—ABCB1—Estrone—prostate cancer	0.0073	0.017	CbGbCtD
Propranolol—CYP3A4—Estramustine—prostate cancer	0.00678	0.0158	CbGbCtD
Propranolol—ABCB1—Ethinyl Estradiol—prostate cancer	0.0065	0.0152	CbGbCtD
Propranolol—CYP3A5—Estradiol—prostate cancer	0.00644	0.015	CbGbCtD
Propranolol—CYP3A4—Abiraterone—prostate cancer	0.00605	0.0141	CbGbCtD
Propranolol—CYP3A4—Flutamide—prostate cancer	0.00605	0.0141	CbGbCtD
Propranolol—CYP1A2—Conjugated Estrogens—prostate cancer	0.00546	0.0127	CbGbCtD
Propranolol—CYP2C19—Estradiol—prostate cancer	0.00519	0.0121	CbGbCtD
Propranolol—CYP3A7—Docetaxel—prostate cancer	0.00513	0.0119	CbGbCtD
Propranolol—CYP3A7-CYP3A51P—Docetaxel—prostate cancer	0.00513	0.0119	CbGbCtD
Propranolol—CYP1A2—Estradiol—prostate cancer	0.00479	0.0112	CbGbCtD
Propranolol—ABCB1—Conjugated Estrogens—prostate cancer	0.00477	0.0111	CbGbCtD
Propranolol—CYP3A4—Cabazitaxel—prostate cancer	0.00447	0.0104	CbGbCtD
Propranolol—CYP2C19—Prednisone—prostate cancer	0.00447	0.0104	CbGbCtD
Propranolol—CYP3A4—Estrone—prostate cancer	0.00437	0.0102	CbGbCtD
Propranolol—ABCB1—Mitoxantrone—prostate cancer	0.00434	0.0101	CbGbCtD
Propranolol—CYP3A5—Etoposide—prostate cancer	0.0042	0.0098	CbGbCtD
Propranolol—ABCB1—Estradiol—prostate cancer	0.00419	0.00976	CbGbCtD
Propranolol—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0039	0.00908	CbGbCtD
Propranolol—CYP3A5—Docetaxel—prostate cancer	0.00385	0.00896	CbGbCtD
Propranolol—ABCB1—Prednisone—prostate cancer	0.0036	0.0084	CbGbCtD
Propranolol—CYP1A2—Etoposide—prostate cancer	0.00313	0.00729	CbGbCtD
Propranolol—CYP3A4—Conjugated Estrogens—prostate cancer	0.00286	0.00666	CbGbCtD
Propranolol—ABCB1—Etoposide—prostate cancer	0.00274	0.00638	CbGbCtD
Propranolol—CYP3A4—Mitoxantrone—prostate cancer	0.0026	0.00606	CbGbCtD
Propranolol—CYP3A4—Estradiol—prostate cancer	0.00251	0.00585	CbGbCtD
Propranolol—ABCB1—Docetaxel—prostate cancer	0.0025	0.00583	CbGbCtD
Propranolol—CYP3A4—Prednisone—prostate cancer	0.00216	0.00503	CbGbCtD
Propranolol—ABCB1—Doxorubicin—prostate cancer	0.00187	0.00435	CbGbCtD
Propranolol—CYP2D6—Doxorubicin—prostate cancer	0.00176	0.0041	CbGbCtD
Propranolol—CYP3A4—Etoposide—prostate cancer	0.00164	0.00382	CbGbCtD
Propranolol—CYP3A4—Docetaxel—prostate cancer	0.0015	0.0035	CbGbCtD
Propranolol—ADRB3—prostate gland—prostate cancer	0.00132	0.126	CbGeAlD
Propranolol—CYP2C19—urine—prostate cancer	0.0012	0.115	CbGeAlD
Propranolol—CYP3A4—Doxorubicin—prostate cancer	0.00112	0.00261	CbGbCtD
Propranolol—CYP1A2—urine—prostate cancer	0.00098	0.0938	CbGeAlD
Propranolol—CYP3A4—urine—prostate cancer	0.00071	0.0679	CbGeAlD
Propranolol—CYP2D6—urine—prostate cancer	0.000698	0.0668	CbGeAlD
Propranolol—ORM1—prostate gland—prostate cancer	0.00061	0.0584	CbGeAlD
Propranolol—SLC22A2—renal system—prostate cancer	0.000539	0.0516	CbGeAlD
Propranolol—ADRB1—prostate gland—prostate cancer	0.000538	0.0515	CbGeAlD
Propranolol—Carvedilol—GJA1—prostate cancer	0.000341	0.0971	CrCbGaD
Propranolol—CYP3A5—prostate gland—prostate cancer	0.000339	0.0325	CbGeAlD
Propranolol—HTR1A—renal system—prostate cancer	0.000315	0.0301	CbGeAlD
Propranolol—ORM1—bone marrow—prostate cancer	0.000314	0.0301	CbGeAlD
Propranolol—Carvedilol—HIF1A—prostate cancer	0.000259	0.0736	CrCbGaD
Propranolol—CYP1A1—epithelium—prostate cancer	0.000255	0.0244	CbGeAlD
Propranolol—CYP1A2—renal system—prostate cancer	0.00024	0.0229	CbGeAlD
Propranolol—CYP1A1—renal system—prostate cancer	0.000237	0.0226	CbGeAlD
Propranolol—CYP1A1—urethra—prostate cancer	0.000232	0.0222	CbGeAlD
Propranolol—CYP3A5—renal system—prostate cancer	0.000231	0.0221	CbGeAlD
Propranolol—ORM1—lymph node—prostate cancer	0.000195	0.0186	CbGeAlD
Propranolol—ABCB1—prostate gland—prostate cancer	0.00018	0.0172	CbGeAlD
Propranolol—CYP3A4—renal system—prostate cancer	0.000174	0.0166	CbGeAlD
Propranolol—Levobunolol—ADRB2—prostate cancer	0.000171	0.0488	CrCbGaD
Propranolol—CYP2D6—renal system—prostate cancer	0.000171	0.0163	CbGeAlD
Propranolol—Acebutolol—SLC22A1—prostate cancer	0.000164	0.0467	CrCbGaD
Propranolol—Metipranolol—ADRB2—prostate cancer	0.000164	0.0465	CrCbGaD
Propranolol—ABCB1—seminal vesicle—prostate cancer	0.000153	0.0146	CbGeAlD
Propranolol—Carteolol—ADRB2—prostate cancer	0.000146	0.0415	CrCbGaD
Propranolol—Terbinafine—CYP19A1—prostate cancer	0.000139	0.0394	CrCbGaD
Propranolol—ABCB1—epithelium—prostate cancer	0.000132	0.0127	CbGeAlD
Propranolol—Esmolol—ADRB2—prostate cancer	0.00013	0.037	CrCbGaD
Propranolol—Bevantolol—ADRB2—prostate cancer	0.000128	0.0365	CrCbGaD
Propranolol—ABCB1—renal system—prostate cancer	0.000123	0.0118	CbGeAlD
Propranolol—ABCB1—urethra—prostate cancer	0.000121	0.0115	CbGeAlD
Propranolol—Bopindolol—ADRB2—prostate cancer	0.000119	0.0338	CrCbGaD
Propranolol—Betaxolol—ADRB2—prostate cancer	0.000114	0.0326	CrCbGaD
Propranolol—Penbutolol—ADRB2—prostate cancer	0.000113	0.0323	CrCbGaD
Propranolol—Atenolol—ADRB2—prostate cancer	0.000113	0.0323	CrCbGaD
Propranolol—CYP1A1—lymph node—prostate cancer	0.000111	0.0106	CbGeAlD
Propranolol—Bisoprolol—ADRB2—prostate cancer	0.00011	0.0314	CrCbGaD
Propranolol—CYP2D6—testis—prostate cancer	0.00011	0.0106	CbGeAlD
Propranolol—Acebutolol—ADRB2—prostate cancer	0.000105	0.0298	CrCbGaD
Propranolol—Carvedilol—VEGFA—prostate cancer	0.000104	0.0296	CrCbGaD
Propranolol—Oxprenolol—ADRB2—prostate cancer	0.000104	0.0296	CrCbGaD
Propranolol—Terbinafine—CYP2C19—prostate cancer	0.000102	0.0291	CrCbGaD
Propranolol—Alprenolol—ADRB2—prostate cancer	9.5e-05	0.027	CrCbGaD
Propranolol—ABCB1—bone marrow—prostate cancer	9.29e-05	0.00889	CbGeAlD
Propranolol—Metoprolol—ADRB2—prostate cancer	8.83e-05	0.0251	CrCbGaD
Propranolol—Pindolol—ADRB2—prostate cancer	8.17e-05	0.0233	CrCbGaD
Propranolol—ABCB1—testis—prostate cancer	7.94e-05	0.0076	CbGeAlD
Propranolol—Metoprolol—CYP2C19—prostate cancer	7.6e-05	0.0216	CrCbGaD
Propranolol—Dizziness—Conjugated Estrogens—prostate cancer	7.45e-05	0.000716	CcSEcCtD
Propranolol—Convulsion—Etoposide—prostate cancer	7.42e-05	0.000713	CcSEcCtD
Propranolol—Dyspepsia—Mitoxantrone—prostate cancer	7.39e-05	0.00071	CcSEcCtD
Propranolol—Gastrointestinal pain—Estradiol—prostate cancer	7.37e-05	0.000708	CcSEcCtD
Propranolol—Cardiac disorder—Capecitabine—prostate cancer	7.34e-05	0.000706	CcSEcCtD
Propranolol—Decreased appetite—Mitoxantrone—prostate cancer	7.3e-05	0.000702	CcSEcCtD
Propranolol—Affect lability—Doxorubicin—prostate cancer	7.26e-05	0.000697	CcSEcCtD
Propranolol—Fatigue—Mitoxantrone—prostate cancer	7.24e-05	0.000696	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—prostate cancer	7.24e-05	0.000696	CcSEcCtD
Propranolol—Vomiting—Goserelin—prostate cancer	7.23e-05	0.000695	CcSEcCtD
Propranolol—Alopecia—Docetaxel—prostate cancer	7.22e-05	0.000694	CcSEcCtD
Propranolol—Pain—Mitoxantrone—prostate cancer	7.18e-05	0.00069	CcSEcCtD
Propranolol—Constipation—Mitoxantrone—prostate cancer	7.18e-05	0.00069	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Epirubicin—prostate cancer	7.17e-05	0.00069	CcSEcCtD
Propranolol—Bradycardia—Prednisone—prostate cancer	7.17e-05	0.00069	CcSEcCtD
Propranolol—Rash—Goserelin—prostate cancer	7.17e-05	0.000689	CcSEcCtD
Propranolol—Dermatitis—Goserelin—prostate cancer	7.16e-05	0.000688	CcSEcCtD
Propranolol—Vomiting—Conjugated Estrogens—prostate cancer	7.16e-05	0.000688	CcSEcCtD
Propranolol—Urticaria—Estradiol—prostate cancer	7.16e-05	0.000688	CcSEcCtD
Propranolol—Mental disorder—Docetaxel—prostate cancer	7.16e-05	0.000688	CcSEcCtD
Propranolol—Abdominal pain—Estradiol—prostate cancer	7.13e-05	0.000685	CcSEcCtD
Propranolol—Body temperature increased—Estradiol—prostate cancer	7.13e-05	0.000685	CcSEcCtD
Propranolol—Erythema—Docetaxel—prostate cancer	7.11e-05	0.000684	CcSEcCtD
Propranolol—Rash—Conjugated Estrogens—prostate cancer	7.1e-05	0.000682	CcSEcCtD
Propranolol—Dermatitis—Conjugated Estrogens—prostate cancer	7.09e-05	0.000682	CcSEcCtD
Propranolol—Hallucination—Prednisone—prostate cancer	7.01e-05	0.000674	CcSEcCtD
Propranolol—Cardiac arrest—Doxorubicin—prostate cancer	7.01e-05	0.000674	CcSEcCtD
Propranolol—Alopecia—Capecitabine—prostate cancer	6.99e-05	0.000672	CcSEcCtD
Propranolol—Anaphylactic shock—Etoposide—prostate cancer	6.99e-05	0.000671	CcSEcCtD
Propranolol—Mood swings—Doxorubicin—prostate cancer	6.98e-05	0.000671	CcSEcCtD
Propranolol—Infection—Etoposide—prostate cancer	6.94e-05	0.000667	CcSEcCtD
Propranolol—Mental disorder—Capecitabine—prostate cancer	6.93e-05	0.000666	CcSEcCtD
Propranolol—Erythema—Capecitabine—prostate cancer	6.89e-05	0.000662	CcSEcCtD
Propranolol—Gastrointestinal pain—Mitoxantrone—prostate cancer	6.87e-05	0.00066	CcSEcCtD
Propranolol—Skin disorder—Etoposide—prostate cancer	6.79e-05	0.000652	CcSEcCtD
Propranolol—Nausea—Goserelin—prostate cancer	6.75e-05	0.000649	CcSEcCtD
Propranolol—Nausea—Conjugated Estrogens—prostate cancer	6.69e-05	0.000643	CcSEcCtD
Propranolol—Urticaria—Mitoxantrone—prostate cancer	6.67e-05	0.000641	CcSEcCtD
Propranolol—Hypersensitivity—Estradiol—prostate cancer	6.64e-05	0.000638	CcSEcCtD
Propranolol—Body temperature increased—Mitoxantrone—prostate cancer	6.64e-05	0.000638	CcSEcCtD
Propranolol—Abdominal pain—Mitoxantrone—prostate cancer	6.64e-05	0.000638	CcSEcCtD
Propranolol—Toxic epidermal necrolysis—Doxorubicin—prostate cancer	6.64e-05	0.000638	CcSEcCtD
Propranolol—Bronchitis—Epirubicin—prostate cancer	6.62e-05	0.000636	CcSEcCtD
Propranolol—Terbinafine—CYP3A4—prostate cancer	6.51e-05	0.0185	CrCbGaD
Propranolol—Ranolazine—CYP3A4—prostate cancer	6.51e-05	0.0185	CrCbGaD
Propranolol—Asthenia—Estradiol—prostate cancer	6.47e-05	0.000622	CcSEcCtD
Propranolol—Neutropenia—Epirubicin—prostate cancer	6.44e-05	0.000619	CcSEcCtD
Propranolol—Paraesthesia—Etoposide—prostate cancer	6.27e-05	0.000603	CcSEcCtD
Propranolol—Cinacalcet—CYP3A4—prostate cancer	6.26e-05	0.0178	CrCbGaD
Propranolol—Dyspnoea—Etoposide—prostate cancer	6.23e-05	0.000599	CcSEcCtD
Propranolol—Alopecia—Prednisone—prostate cancer	6.23e-05	0.000599	CcSEcCtD
Propranolol—Somnolence—Etoposide—prostate cancer	6.21e-05	0.000597	CcSEcCtD
Propranolol—Cough—Docetaxel—prostate cancer	6.21e-05	0.000597	CcSEcCtD
Propranolol—Vertigo—Capecitabine—prostate cancer	6.19e-05	0.000595	CcSEcCtD
Propranolol—Hypersensitivity—Mitoxantrone—prostate cancer	6.19e-05	0.000595	CcSEcCtD
Propranolol—Mental disorder—Prednisone—prostate cancer	6.17e-05	0.000593	CcSEcCtD
Propranolol—Diarrhoea—Estradiol—prostate cancer	6.17e-05	0.000593	CcSEcCtD
Propranolol—Convulsion—Docetaxel—prostate cancer	6.16e-05	0.000592	CcSEcCtD
Propranolol—Infestation NOS—Epirubicin—prostate cancer	6.14e-05	0.00059	CcSEcCtD
Propranolol—Infestation—Epirubicin—prostate cancer	6.14e-05	0.00059	CcSEcCtD
Propranolol—Erythema—Prednisone—prostate cancer	6.13e-05	0.00059	CcSEcCtD
Propranolol—Bronchitis—Doxorubicin—prostate cancer	6.13e-05	0.000589	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Epirubicin—prostate cancer	6.09e-05	0.000585	CcSEcCtD
Propranolol—Decreased appetite—Etoposide—prostate cancer	6.07e-05	0.000584	CcSEcCtD
Propranolol—Bisoprolol—CYP3A4—prostate cancer	6.05e-05	0.0172	CrCbGaD
Propranolol—Gastrointestinal disorder—Etoposide—prostate cancer	6.03e-05	0.00058	CcSEcCtD
Propranolol—Asthenia—Mitoxantrone—prostate cancer	6.03e-05	0.000579	CcSEcCtD
Propranolol—Fatigue—Etoposide—prostate cancer	6.02e-05	0.000579	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—prostate cancer	6.01e-05	0.000578	CcSEcCtD
Propranolol—Cough—Capecitabine—prostate cancer	6.01e-05	0.000578	CcSEcCtD
Propranolol—Constipation—Etoposide—prostate cancer	5.97e-05	0.000574	CcSEcCtD
Propranolol—Pain—Etoposide—prostate cancer	5.97e-05	0.000574	CcSEcCtD
Propranolol—Dizziness—Estradiol—prostate cancer	5.96e-05	0.000573	CcSEcCtD
Propranolol—Neutropenia—Doxorubicin—prostate cancer	5.96e-05	0.000573	CcSEcCtD
Propranolol—Carvedilol—ADRB2—prostate cancer	5.86e-05	0.0167	CrCbGaD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—prostate cancer	5.82e-05	0.00056	CcSEcCtD
Propranolol—Anaphylactic shock—Docetaxel—prostate cancer	5.81e-05	0.000558	CcSEcCtD
Propranolol—Infection—Docetaxel—prostate cancer	5.77e-05	0.000554	CcSEcCtD
Propranolol—ABCB1—lymph node—prostate cancer	5.76e-05	0.00551	CbGeAlD
Propranolol—Diarrhoea—Mitoxantrone—prostate cancer	5.75e-05	0.000552	CcSEcCtD
Propranolol—Vomiting—Estradiol—prostate cancer	5.73e-05	0.000551	CcSEcCtD
Propranolol—Agranulocytosis—Epirubicin—prostate cancer	5.73e-05	0.000551	CcSEcCtD
Propranolol—Gastrointestinal pain—Etoposide—prostate cancer	5.71e-05	0.000549	CcSEcCtD
Propranolol—Nervous system disorder—Docetaxel—prostate cancer	5.69e-05	0.000547	CcSEcCtD
Propranolol—Rash—Estradiol—prostate cancer	5.68e-05	0.000546	CcSEcCtD
Propranolol—Infestation—Doxorubicin—prostate cancer	5.68e-05	0.000546	CcSEcCtD
Propranolol—Infestation NOS—Doxorubicin—prostate cancer	5.68e-05	0.000546	CcSEcCtD
Propranolol—Dermatitis—Estradiol—prostate cancer	5.68e-05	0.000546	CcSEcCtD
Propranolol—Skin disorder—Docetaxel—prostate cancer	5.64e-05	0.000542	CcSEcCtD
Propranolol—Agitation—Prednisone—prostate cancer	5.64e-05	0.000542	CcSEcCtD
Propranolol—Stevens-Johnson syndrome—Doxorubicin—prostate cancer	5.63e-05	0.000541	CcSEcCtD
Propranolol—Bradycardia—Epirubicin—prostate cancer	5.61e-05	0.000539	CcSEcCtD
Propranolol—Infection—Capecitabine—prostate cancer	5.58e-05	0.000537	CcSEcCtD
Propranolol—Urticaria—Etoposide—prostate cancer	5.55e-05	0.000533	CcSEcCtD
Propranolol—Body temperature increased—Etoposide—prostate cancer	5.52e-05	0.000531	CcSEcCtD
Propranolol—Abdominal pain—Etoposide—prostate cancer	5.52e-05	0.000531	CcSEcCtD
Propranolol—Nervous system disorder—Capecitabine—prostate cancer	5.51e-05	0.00053	CcSEcCtD
Propranolol—Vertigo—Prednisone—prostate cancer	5.51e-05	0.00053	CcSEcCtD
Propranolol—Pharyngitis—Epirubicin—prostate cancer	5.47e-05	0.000526	CcSEcCtD
Propranolol—Skin disorder—Capecitabine—prostate cancer	5.46e-05	0.000525	CcSEcCtD
Propranolol—Nausea—Estradiol—prostate cancer	5.35e-05	0.000515	CcSEcCtD
Propranolol—Vomiting—Mitoxantrone—prostate cancer	5.34e-05	0.000513	CcSEcCtD
Propranolol—Convulsion—Prednisone—prostate cancer	5.32e-05	0.000511	CcSEcCtD
Propranolol—Visual impairment—Epirubicin—prostate cancer	5.31e-05	0.00051	CcSEcCtD
Propranolol—Agranulocytosis—Doxorubicin—prostate cancer	5.3e-05	0.00051	CcSEcCtD
Propranolol—Rash—Mitoxantrone—prostate cancer	5.3e-05	0.000509	CcSEcCtD
Propranolol—Dermatitis—Mitoxantrone—prostate cancer	5.29e-05	0.000508	CcSEcCtD
Propranolol—Insomnia—Docetaxel—prostate cancer	5.25e-05	0.000505	CcSEcCtD
Propranolol—Paraesthesia—Docetaxel—prostate cancer	5.21e-05	0.000501	CcSEcCtD
Propranolol—Erythema multiforme—Epirubicin—prostate cancer	5.21e-05	0.000501	CcSEcCtD
Propranolol—Bradycardia—Doxorubicin—prostate cancer	5.19e-05	0.000499	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	5.19e-05	0.000499	CcSEcCtD
Propranolol—Dyspnoea—Docetaxel—prostate cancer	5.18e-05	0.000497	CcSEcCtD
Propranolol—Somnolence—Docetaxel—prostate cancer	5.16e-05	0.000496	CcSEcCtD
Propranolol—Hypersensitivity—Etoposide—prostate cancer	5.15e-05	0.000495	CcSEcCtD
Propranolol—Cardiac disorder—Epirubicin—prostate cancer	5.12e-05	0.000492	CcSEcCtD
Propranolol—Dyspepsia—Docetaxel—prostate cancer	5.11e-05	0.000491	CcSEcCtD
Propranolol—Carvedilol—CYP2E1—prostate cancer	5.1e-05	0.0145	CrCbGaD
Propranolol—Insomnia—Capecitabine—prostate cancer	5.08e-05	0.000489	CcSEcCtD
Propranolol—Pharyngitis—Doxorubicin—prostate cancer	5.06e-05	0.000486	CcSEcCtD
Propranolol—Paraesthesia—Capecitabine—prostate cancer	5.05e-05	0.000485	CcSEcCtD
Propranolol—Decreased appetite—Docetaxel—prostate cancer	5.05e-05	0.000485	CcSEcCtD
Propranolol—Carvedilol—CYP1A1—prostate cancer	5.03e-05	0.0143	CrCbGaD
Propranolol—Gastrointestinal disorder—Docetaxel—prostate cancer	5.01e-05	0.000482	CcSEcCtD
Propranolol—Asthenia—Etoposide—prostate cancer	5.01e-05	0.000482	CcSEcCtD
Propranolol—Dyspnoea—Capecitabine—prostate cancer	5.01e-05	0.000482	CcSEcCtD
Propranolol—Anaphylactic shock—Prednisone—prostate cancer	5.01e-05	0.000481	CcSEcCtD
Propranolol—Fatigue—Docetaxel—prostate cancer	5.01e-05	0.000481	CcSEcCtD
Propranolol—Nausea—Mitoxantrone—prostate cancer	4.99e-05	0.000479	CcSEcCtD
Propranolol—Infection—Prednisone—prostate cancer	4.97e-05	0.000478	CcSEcCtD
Propranolol—Pain—Docetaxel—prostate cancer	4.96e-05	0.000477	CcSEcCtD
Propranolol—Constipation—Docetaxel—prostate cancer	4.96e-05	0.000477	CcSEcCtD
Propranolol—Dyspepsia—Capecitabine—prostate cancer	4.95e-05	0.000476	CcSEcCtD
Propranolol—Visual impairment—Doxorubicin—prostate cancer	4.91e-05	0.000472	CcSEcCtD
Propranolol—Nervous system disorder—Prednisone—prostate cancer	4.91e-05	0.000472	CcSEcCtD
Propranolol—Decreased appetite—Capecitabine—prostate cancer	4.89e-05	0.00047	CcSEcCtD
Propranolol—Alopecia—Epirubicin—prostate cancer	4.87e-05	0.000468	CcSEcCtD
Propranolol—Skin disorder—Prednisone—prostate cancer	4.86e-05	0.000467	CcSEcCtD
Propranolol—Gastrointestinal disorder—Capecitabine—prostate cancer	4.85e-05	0.000466	CcSEcCtD
Propranolol—Fatigue—Capecitabine—prostate cancer	4.85e-05	0.000466	CcSEcCtD
Propranolol—Mental disorder—Epirubicin—prostate cancer	4.83e-05	0.000464	CcSEcCtD
Propranolol—Erythema multiforme—Doxorubicin—prostate cancer	4.82e-05	0.000463	CcSEcCtD
Propranolol—Constipation—Capecitabine—prostate cancer	4.81e-05	0.000462	CcSEcCtD
Propranolol—Pain—Capecitabine—prostate cancer	4.81e-05	0.000462	CcSEcCtD
Propranolol—Erythema—Epirubicin—prostate cancer	4.8e-05	0.000461	CcSEcCtD
Propranolol—Diarrhoea—Etoposide—prostate cancer	4.78e-05	0.000459	CcSEcCtD
Propranolol—Gastrointestinal pain—Docetaxel—prostate cancer	4.75e-05	0.000456	CcSEcCtD
Propranolol—Cardiac disorder—Doxorubicin—prostate cancer	4.73e-05	0.000455	CcSEcCtD
Propranolol—Dizziness—Etoposide—prostate cancer	4.62e-05	0.000444	CcSEcCtD
Propranolol—Gastrointestinal pain—Capecitabine—prostate cancer	4.6e-05	0.000442	CcSEcCtD
Propranolol—Body temperature increased—Docetaxel—prostate cancer	4.59e-05	0.000441	CcSEcCtD
Propranolol—Abdominal pain—Docetaxel—prostate cancer	4.59e-05	0.000441	CcSEcCtD
Propranolol—Insomnia—Prednisone—prostate cancer	4.53e-05	0.000435	CcSEcCtD
Propranolol—Alopecia—Doxorubicin—prostate cancer	4.51e-05	0.000433	CcSEcCtD
Propranolol—Paraesthesia—Prednisone—prostate cancer	4.5e-05	0.000432	CcSEcCtD
Propranolol—Mental disorder—Doxorubicin—prostate cancer	4.47e-05	0.000429	CcSEcCtD
Propranolol—Urticaria—Capecitabine—prostate cancer	4.47e-05	0.000429	CcSEcCtD
Propranolol—Abdominal pain—Capecitabine—prostate cancer	4.44e-05	0.000427	CcSEcCtD
Propranolol—Body temperature increased—Capecitabine—prostate cancer	4.44e-05	0.000427	CcSEcCtD
Propranolol—Vomiting—Etoposide—prostate cancer	4.44e-05	0.000427	CcSEcCtD
Propranolol—Erythema—Doxorubicin—prostate cancer	4.44e-05	0.000427	CcSEcCtD
Propranolol—Agitation—Epirubicin—prostate cancer	4.41e-05	0.000424	CcSEcCtD
Propranolol—Dyspepsia—Prednisone—prostate cancer	4.41e-05	0.000424	CcSEcCtD
Propranolol—Rash—Etoposide—prostate cancer	4.4e-05	0.000423	CcSEcCtD
Propranolol—Dermatitis—Etoposide—prostate cancer	4.4e-05	0.000423	CcSEcCtD
Propranolol—Decreased appetite—Prednisone—prostate cancer	4.35e-05	0.000418	CcSEcCtD
Propranolol—Fatigue—Prednisone—prostate cancer	4.32e-05	0.000415	CcSEcCtD
Propranolol—Vertigo—Epirubicin—prostate cancer	4.31e-05	0.000414	CcSEcCtD
Propranolol—Constipation—Prednisone—prostate cancer	4.28e-05	0.000411	CcSEcCtD
Propranolol—Hypersensitivity—Docetaxel—prostate cancer	4.28e-05	0.000411	CcSEcCtD
Propranolol—Cough—Epirubicin—prostate cancer	4.19e-05	0.000402	CcSEcCtD
Propranolol—Asthenia—Docetaxel—prostate cancer	4.17e-05	0.0004	CcSEcCtD
Propranolol—Convulsion—Epirubicin—prostate cancer	4.16e-05	0.0004	CcSEcCtD
Propranolol—Nausea—Etoposide—prostate cancer	4.15e-05	0.000399	CcSEcCtD
Propranolol—Hypersensitivity—Capecitabine—prostate cancer	4.14e-05	0.000398	CcSEcCtD
Propranolol—Gastrointestinal pain—Prednisone—prostate cancer	4.09e-05	0.000393	CcSEcCtD
Propranolol—Agitation—Doxorubicin—prostate cancer	4.08e-05	0.000392	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	4.06e-05	0.00039	CcSEcCtD
Propranolol—Atomoxetine—CYP2C19—prostate cancer	4.04e-05	0.0115	CrCbGaD
Propranolol—Asthenia—Capecitabine—prostate cancer	4.03e-05	0.000388	CcSEcCtD
Propranolol—Vertigo—Doxorubicin—prostate cancer	3.99e-05	0.000383	CcSEcCtD
Propranolol—Urticaria—Prednisone—prostate cancer	3.98e-05	0.000382	CcSEcCtD
Propranolol—Diarrhoea—Docetaxel—prostate cancer	3.97e-05	0.000382	CcSEcCtD
Propranolol—Abdominal pain—Prednisone—prostate cancer	3.96e-05	0.00038	CcSEcCtD
Propranolol—Body temperature increased—Prednisone—prostate cancer	3.96e-05	0.00038	CcSEcCtD
Propranolol—Anaphylactic shock—Epirubicin—prostate cancer	3.92e-05	0.000376	CcSEcCtD
Propranolol—Infection—Epirubicin—prostate cancer	3.89e-05	0.000374	CcSEcCtD
Propranolol—Cough—Doxorubicin—prostate cancer	3.87e-05	0.000372	CcSEcCtD
Propranolol—Convulsion—Doxorubicin—prostate cancer	3.85e-05	0.00037	CcSEcCtD
Propranolol—Diarrhoea—Capecitabine—prostate cancer	3.85e-05	0.00037	CcSEcCtD
Propranolol—Nervous system disorder—Epirubicin—prostate cancer	3.84e-05	0.000369	CcSEcCtD
Propranolol—Dizziness—Docetaxel—prostate cancer	3.84e-05	0.000369	CcSEcCtD
Propranolol—Skin disorder—Epirubicin—prostate cancer	3.8e-05	0.000366	CcSEcCtD
Propranolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	3.75e-05	0.000361	CcSEcCtD
Propranolol—Dizziness—Capecitabine—prostate cancer	3.72e-05	0.000357	CcSEcCtD
Propranolol—Vomiting—Docetaxel—prostate cancer	3.69e-05	0.000355	CcSEcCtD
Propranolol—Hypersensitivity—Prednisone—prostate cancer	3.69e-05	0.000355	CcSEcCtD
Propranolol—Rash—Docetaxel—prostate cancer	3.66e-05	0.000352	CcSEcCtD
Propranolol—Dermatitis—Docetaxel—prostate cancer	3.66e-05	0.000351	CcSEcCtD
Propranolol—Anaphylactic shock—Doxorubicin—prostate cancer	3.62e-05	0.000348	CcSEcCtD
Propranolol—Infection—Doxorubicin—prostate cancer	3.6e-05	0.000346	CcSEcCtD
Propranolol—Asthenia—Prednisone—prostate cancer	3.59e-05	0.000345	CcSEcCtD
Propranolol—Vomiting—Capecitabine—prostate cancer	3.57e-05	0.000343	CcSEcCtD
Propranolol—Propafenone—CYP3A4—prostate cancer	3.56e-05	0.0101	CrCbGaD
Propranolol—Nervous system disorder—Doxorubicin—prostate cancer	3.55e-05	0.000341	CcSEcCtD
Propranolol—Rash—Capecitabine—prostate cancer	3.54e-05	0.000341	CcSEcCtD
Propranolol—Insomnia—Epirubicin—prostate cancer	3.54e-05	0.00034	CcSEcCtD
Propranolol—Dermatitis—Capecitabine—prostate cancer	3.54e-05	0.00034	CcSEcCtD
Propranolol—Skin disorder—Doxorubicin—prostate cancer	3.52e-05	0.000338	CcSEcCtD
Propranolol—Paraesthesia—Epirubicin—prostate cancer	3.52e-05	0.000338	CcSEcCtD
Propranolol—Dyspnoea—Epirubicin—prostate cancer	3.49e-05	0.000336	CcSEcCtD
Propranolol—Somnolence—Epirubicin—prostate cancer	3.48e-05	0.000335	CcSEcCtD
Propranolol—Nausea—Docetaxel—prostate cancer	3.45e-05	0.000331	CcSEcCtD
Propranolol—Dyspepsia—Epirubicin—prostate cancer	3.45e-05	0.000331	CcSEcCtD
Propranolol—Diarrhoea—Prednisone—prostate cancer	3.43e-05	0.000329	CcSEcCtD
Propranolol—Decreased appetite—Epirubicin—prostate cancer	3.4e-05	0.000327	CcSEcCtD
Propranolol—Gastrointestinal disorder—Epirubicin—prostate cancer	3.38e-05	0.000325	CcSEcCtD
Propranolol—Fatigue—Epirubicin—prostate cancer	3.38e-05	0.000324	CcSEcCtD
Propranolol—Constipation—Epirubicin—prostate cancer	3.35e-05	0.000322	CcSEcCtD
Propranolol—Pain—Epirubicin—prostate cancer	3.35e-05	0.000322	CcSEcCtD
Propranolol—Nausea—Capecitabine—prostate cancer	3.34e-05	0.000321	CcSEcCtD
Propranolol—Dizziness—Prednisone—prostate cancer	3.31e-05	0.000318	CcSEcCtD
Propranolol—Insomnia—Doxorubicin—prostate cancer	3.28e-05	0.000315	CcSEcCtD
Propranolol—Paraesthesia—Doxorubicin—prostate cancer	3.25e-05	0.000313	CcSEcCtD
Propranolol—Dyspnoea—Doxorubicin—prostate cancer	3.23e-05	0.00031	CcSEcCtD
Propranolol—Somnolence—Doxorubicin—prostate cancer	3.22e-05	0.00031	CcSEcCtD
Propranolol—Carvedilol—CYP3A4—prostate cancer	3.21e-05	0.00913	CrCbGaD
Propranolol—Gastrointestinal pain—Epirubicin—prostate cancer	3.2e-05	0.000308	CcSEcCtD
Propranolol—Dyspepsia—Doxorubicin—prostate cancer	3.19e-05	0.000307	CcSEcCtD
Propranolol—Vomiting—Prednisone—prostate cancer	3.18e-05	0.000306	CcSEcCtD
Propranolol—Rash—Prednisone—prostate cancer	3.16e-05	0.000303	CcSEcCtD
Propranolol—Dermatitis—Prednisone—prostate cancer	3.15e-05	0.000303	CcSEcCtD
Propranolol—Decreased appetite—Doxorubicin—prostate cancer	3.15e-05	0.000303	CcSEcCtD
Propranolol—Gastrointestinal disorder—Doxorubicin—prostate cancer	3.13e-05	0.000301	CcSEcCtD
Propranolol—Fatigue—Doxorubicin—prostate cancer	3.12e-05	0.0003	CcSEcCtD
Propranolol—Urticaria—Epirubicin—prostate cancer	3.11e-05	0.000299	CcSEcCtD
Propranolol—Constipation—Doxorubicin—prostate cancer	3.1e-05	0.000298	CcSEcCtD
Propranolol—Pain—Doxorubicin—prostate cancer	3.1e-05	0.000298	CcSEcCtD
Propranolol—Abdominal pain—Epirubicin—prostate cancer	3.1e-05	0.000298	CcSEcCtD
Propranolol—Body temperature increased—Epirubicin—prostate cancer	3.1e-05	0.000298	CcSEcCtD
Propranolol—Nausea—Prednisone—prostate cancer	2.97e-05	0.000286	CcSEcCtD
Propranolol—Gastrointestinal pain—Doxorubicin—prostate cancer	2.96e-05	0.000285	CcSEcCtD
Propranolol—Hypersensitivity—Epirubicin—prostate cancer	2.88e-05	0.000277	CcSEcCtD
Propranolol—Urticaria—Doxorubicin—prostate cancer	2.88e-05	0.000277	CcSEcCtD
Propranolol—Abdominal pain—Doxorubicin—prostate cancer	2.86e-05	0.000275	CcSEcCtD
Propranolol—Body temperature increased—Doxorubicin—prostate cancer	2.86e-05	0.000275	CcSEcCtD
Propranolol—Asthenia—Epirubicin—prostate cancer	2.81e-05	0.00027	CcSEcCtD
Propranolol—Diarrhoea—Epirubicin—prostate cancer	2.68e-05	0.000257	CcSEcCtD
Propranolol—Hypersensitivity—Doxorubicin—prostate cancer	2.67e-05	0.000257	CcSEcCtD
Propranolol—Asthenia—Doxorubicin—prostate cancer	2.6e-05	0.00025	CcSEcCtD
Propranolol—Dizziness—Epirubicin—prostate cancer	2.59e-05	0.000249	CcSEcCtD
Propranolol—Atomoxetine—CYP3A4—prostate cancer	2.57e-05	0.00731	CrCbGaD
Propranolol—Vomiting—Epirubicin—prostate cancer	2.49e-05	0.000239	CcSEcCtD
Propranolol—Diarrhoea—Doxorubicin—prostate cancer	2.48e-05	0.000238	CcSEcCtD
Propranolol—Rash—Epirubicin—prostate cancer	2.47e-05	0.000237	CcSEcCtD
Propranolol—Dermatitis—Epirubicin—prostate cancer	2.47e-05	0.000237	CcSEcCtD
Propranolol—Dizziness—Doxorubicin—prostate cancer	2.4e-05	0.00023	CcSEcCtD
Propranolol—Nausea—Epirubicin—prostate cancer	2.33e-05	0.000224	CcSEcCtD
Propranolol—Vomiting—Doxorubicin—prostate cancer	2.3e-05	0.000221	CcSEcCtD
Propranolol—Rash—Doxorubicin—prostate cancer	2.28e-05	0.00022	CcSEcCtD
Propranolol—Dermatitis—Doxorubicin—prostate cancer	2.28e-05	0.000219	CcSEcCtD
Propranolol—Nausea—Doxorubicin—prostate cancer	2.15e-05	0.000207	CcSEcCtD
Propranolol—CYP1A2—Metabolism—GGT1—prostate cancer	1.64e-06	1.86e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—JAK2—prostate cancer	1.63e-06	1.85e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—ERCC2—prostate cancer	1.63e-06	1.85e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—FGF2—prostate cancer	1.63e-06	1.85e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP2A6—prostate cancer	1.62e-06	1.84e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—TYMS—prostate cancer	1.61e-06	1.83e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—NCOA1—prostate cancer	1.61e-06	1.83e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—NOS3—prostate cancer	1.6e-06	1.82e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CYP1A1—prostate cancer	1.6e-06	1.82e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—EP300—prostate cancer	1.6e-06	1.82e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—PIK3CA—prostate cancer	1.6e-06	1.82e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—JAK2—prostate cancer	1.59e-06	1.81e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—GSTM1—prostate cancer	1.59e-06	1.81e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MDM2—prostate cancer	1.59e-06	1.81e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—ERCC2—prostate cancer	1.59e-06	1.81e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—PIK3CA—prostate cancer	1.59e-06	1.81e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CYP19A1—prostate cancer	1.59e-06	1.81e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—INS—prostate cancer	1.58e-06	1.79e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—AKR1C3—prostate cancer	1.57e-06	1.79e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CG—prostate cancer	1.57e-06	1.79e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—ERBB2—prostate cancer	1.57e-06	1.78e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PRKACB—prostate cancer	1.56e-06	1.78e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—LPL—prostate cancer	1.56e-06	1.78e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—PIK3CA—prostate cancer	1.56e-06	1.78e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—JAK2—prostate cancer	1.56e-06	1.77e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—SRC—prostate cancer	1.56e-06	1.77e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MDM2—prostate cancer	1.56e-06	1.77e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP17A1—prostate cancer	1.55e-06	1.76e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PIK3CB—prostate cancer	1.55e-06	1.76e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—CREBBP—prostate cancer	1.54e-06	1.75e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—TP53—prostate cancer	1.54e-06	1.75e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—ERBB2—prostate cancer	1.53e-06	1.74e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—RXRA—prostate cancer	1.53e-06	1.74e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—MTHFR—prostate cancer	1.53e-06	1.74e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—PIK3CA—prostate cancer	1.53e-06	1.74e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PTEN—prostate cancer	1.52e-06	1.73e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PTEN—prostate cancer	1.52e-06	1.73e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MDM2—prostate cancer	1.52e-06	1.73e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—VEGFA—prostate cancer	1.52e-06	1.72e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PIK3CB—prostate cancer	1.51e-06	1.72e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CYP1A1—prostate cancer	1.51e-06	1.72e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PPARA—prostate cancer	1.5e-06	1.71e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—STAT3—prostate cancer	1.5e-06	1.71e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—ERBB2—prostate cancer	1.5e-06	1.71e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—ERCC2—prostate cancer	1.5e-06	1.7e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—MTHFR—prostate cancer	1.49e-06	1.7e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.49e-06	1.69e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—INS—prostate cancer	1.49e-06	1.69e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CXCL8—prostate cancer	1.49e-06	1.69e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PIK3CB—prostate cancer	1.48e-06	1.68e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—COMT—prostate cancer	1.48e-06	1.68e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NCOA2—prostate cancer	1.48e-06	1.68e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GSTP1—prostate cancer	1.47e-06	1.67e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PPARA—prostate cancer	1.47e-06	1.67e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CD—prostate cancer	1.46e-06	1.66e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—CREBBP—prostate cancer	1.46e-06	1.66e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CXCL8—prostate cancer	1.45e-06	1.65e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—EP300—prostate cancer	1.45e-06	1.65e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CDKN1B—prostate cancer	1.45e-06	1.65e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—EP300—prostate cancer	1.45e-06	1.65e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ITPR1—prostate cancer	1.45e-06	1.64e-05	CbGpPWpGaD
Propranolol—ADRB1—GPCR downstream signaling—AKT1—prostate cancer	1.44e-06	1.63e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CASP3—prostate cancer	1.42e-06	1.62e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CXCL8—prostate cancer	1.42e-06	1.62e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.42e-06	1.62e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL2—prostate cancer	1.42e-06	1.62e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CDKN1B—prostate cancer	1.42e-06	1.62e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—IL6—prostate cancer	1.41e-06	1.61e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CAV1—prostate cancer	1.41e-06	1.61e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—MTHFR—prostate cancer	1.41e-06	1.6e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—IL6—prostate cancer	1.41e-06	1.6e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—SLC5A5—prostate cancer	1.41e-06	1.6e-05	CbGpPWpGaD
Propranolol—ADRB2—GPCR downstream signaling—AKT1—prostate cancer	1.41e-06	1.6e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—MYC—prostate cancer	1.4e-06	1.59e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CASP3—prostate cancer	1.39e-06	1.58e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TGFB1—prostate cancer	1.39e-06	1.58e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL2—prostate cancer	1.39e-06	1.58e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CDKN1B—prostate cancer	1.39e-06	1.58e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CCND1—prostate cancer	1.39e-06	1.58e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—IL6—prostate cancer	1.38e-06	1.57e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CD—prostate cancer	1.38e-06	1.57e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PPARA—prostate cancer	1.38e-06	1.57e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—NOS3—prostate cancer	1.38e-06	1.57e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CAV1—prostate cancer	1.38e-06	1.57e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP2E1—prostate cancer	1.37e-06	1.56e-05	CbGpPWpGaD
Propranolol—HTR1A—GPCR downstream signaling—AKT1—prostate cancer	1.37e-06	1.56e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CTNNB1—prostate cancer	1.37e-06	1.56e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—TYMS—prostate cancer	1.37e-06	1.55e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—EGFR—prostate cancer	1.36e-06	1.55e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CASP3—prostate cancer	1.36e-06	1.55e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL2—prostate cancer	1.36e-06	1.55e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NQO1—prostate cancer	1.36e-06	1.55e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CCND1—prostate cancer	1.36e-06	1.54e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—IL6—prostate cancer	1.35e-06	1.54e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—GSTM1—prostate cancer	1.35e-06	1.54e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.35e-06	1.53e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MMP9—prostate cancer	1.35e-06	1.53e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CTNNB1—prostate cancer	1.34e-06	1.53e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—CDKN1A—prostate cancer	1.34e-06	1.52e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—TH—prostate cancer	1.34e-06	1.52e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PTEN—prostate cancer	1.34e-06	1.52e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CCND1—prostate cancer	1.33e-06	1.51e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—LPL—prostate cancer	1.33e-06	1.51e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MMP9—prostate cancer	1.32e-06	1.5e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CTNNB1—prostate cancer	1.31e-06	1.49e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—CDKN1A—prostate cancer	1.31e-06	1.49e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PTEN—prostate cancer	1.31e-06	1.49e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—NOS3—prostate cancer	1.31e-06	1.48e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling by GPCR—AKT1—prostate cancer	1.3e-06	1.48e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP1B1—prostate cancer	1.3e-06	1.48e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CAV1—prostate cancer	1.3e-06	1.48e-05	CbGpPWpGaD
Propranolol—ADRB3—Signaling Pathways—AKT1—prostate cancer	1.3e-06	1.48e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—KRAS—prostate cancer	1.29e-06	1.47e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MMP9—prostate cancer	1.29e-06	1.46e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CG—prostate cancer	1.29e-06	1.46e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—CDKN1A—prostate cancer	1.28e-06	1.46e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CYP1A1—prostate cancer	1.28e-06	1.46e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PTEN—prostate cancer	1.28e-06	1.45e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling by GPCR—AKT1—prostate cancer	1.28e-06	1.45e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—EP300—prostate cancer	1.28e-06	1.45e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CB—prostate cancer	1.28e-06	1.45e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—ERCC2—prostate cancer	1.27e-06	1.44e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PTGS2—prostate cancer	1.26e-06	1.44e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GGT1—prostate cancer	1.26e-06	1.44e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CG—prostate cancer	1.26e-06	1.43e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling by GPCR—AKT1—prostate cancer	1.25e-06	1.42e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—EP300—prostate cancer	1.25e-06	1.42e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NCOA1—prostate cancer	1.24e-06	1.41e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—SRC—prostate cancer	1.24e-06	1.41e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP19A1—prostate cancer	1.23e-06	1.39e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—EP300—prostate cancer	1.22e-06	1.39e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—INS—prostate cancer	1.22e-06	1.38e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—SRC—prostate cancer	1.21e-06	1.38e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—VEGFA—prostate cancer	1.21e-06	1.37e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CB—prostate cancer	1.2e-06	1.37e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—STAT3—prostate cancer	1.2e-06	1.36e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PTGS2—prostate cancer	1.19e-06	1.36e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—MTHFR—prostate cancer	1.19e-06	1.36e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—CREBBP—prostate cancer	1.19e-06	1.36e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—INS—prostate cancer	1.19e-06	1.35e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—SRC—prostate cancer	1.19e-06	1.35e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—PIK3CA—prostate cancer	1.18e-06	1.35e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CG—prostate cancer	1.18e-06	1.35e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—RXRA—prostate cancer	1.18e-06	1.34e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—VEGFA—prostate cancer	1.18e-06	1.34e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PPARA—prostate cancer	1.17e-06	1.33e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—STAT3—prostate cancer	1.17e-06	1.33e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—CREBBP—prostate cancer	1.16e-06	1.32e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—VEGFA—prostate cancer	1.16e-06	1.31e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—TP53—prostate cancer	1.15e-06	1.3e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—STAT3—prostate cancer	1.14e-06	1.3e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—COMT—prostate cancer	1.14e-06	1.3e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GSTP1—prostate cancer	1.13e-06	1.29e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CD—prostate cancer	1.13e-06	1.29e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—INS—prostate cancer	1.12e-06	1.27e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ITPR1—prostate cancer	1.12e-06	1.27e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—MYC—prostate cancer	1.11e-06	1.26e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TGFB1—prostate cancer	1.11e-06	1.26e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CD—prostate cancer	1.1e-06	1.26e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PTEN—prostate cancer	1.1e-06	1.25e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CAV1—prostate cancer	1.1e-06	1.25e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—CREBBP—prostate cancer	1.1e-06	1.25e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—MYC—prostate cancer	1.09e-06	1.24e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—EGFR—prostate cancer	1.09e-06	1.24e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TGFB1—prostate cancer	1.08e-06	1.23e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—PIK3CA—prostate cancer	1.08e-06	1.22e-05	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—PIK3CA—prostate cancer	1.07e-06	1.22e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—NOS3—prostate cancer	1.07e-06	1.21e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—EGFR—prostate cancer	1.06e-06	1.21e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—MYC—prostate cancer	1.06e-06	1.21e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TGFB1—prostate cancer	1.06e-06	1.21e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—TYMS—prostate cancer	1.05e-06	1.2e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.05e-06	1.2e-05	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—EP300—prostate cancer	1.05e-06	1.2e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—IL6—prostate cancer	1.05e-06	1.19e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—NOS3—prostate cancer	1.04e-06	1.19e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—GSTM1—prostate cancer	1.04e-06	1.18e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PTEN—prostate cancer	1.04e-06	1.18e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CD—prostate cancer	1.04e-06	1.18e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—EGFR—prostate cancer	1.04e-06	1.18e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—KRAS—prostate cancer	1.03e-06	1.17e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—LPL—prostate cancer	1.02e-06	1.16e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—KRAS—prostate cancer	1e-06	1.14e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CG—prostate cancer	1e-06	1.14e-05	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—EP300—prostate cancer	9.93e-07	1.13e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CYP1A1—prostate cancer	9.88e-07	1.12e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CB—prostate cancer	9.86e-07	1.12e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—NOS3—prostate cancer	9.82e-07	1.12e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—KRAS—prostate cancer	9.82e-07	1.12e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—ERCC2—prostate cancer	9.8e-07	1.11e-05	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PTGS2—prostate cancer	9.77e-07	1.11e-05	CbGpPWpGaD
Propranolol—HTR1B—Signaling Pathways—AKT1—prostate cancer	9.68e-07	1.1e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CB—prostate cancer	9.62e-07	1.09e-05	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PTGS2—prostate cancer	9.53e-07	1.08e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—INS—prostate cancer	9.49e-07	1.08e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—PIK3CA—prostate cancer	9.43e-07	1.07e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—CREBBP—prostate cancer	9.29e-07	1.06e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—PIK3CA—prostate cancer	9.23e-07	1.05e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—MTHFR—prostate cancer	9.21e-07	1.05e-05	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—TP53—prostate cancer	9.13e-07	1.04e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CB—prostate cancer	9.07e-07	1.03e-05	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PPARA—prostate cancer	9.03e-07	1.03e-05	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	9.02e-07	1.03e-05	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PTGS2—prostate cancer	8.98e-07	1.02e-05	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—TP53—prostate cancer	8.93e-07	1.02e-05	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CD—prostate cancer	8.81e-07	1e-05	CbGpPWpGaD
Propranolol—CYP3A7—Metabolism—AKT1—prostate cancer	8.78e-07	9.99e-06	CbGpPWpGaD
Propranolol—SLC22A2—Metabolism—AKT1—prostate cancer	8.77e-07	9.97e-06	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—TP53—prostate cancer	8.73e-07	9.93e-06	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PTEN—prostate cancer	8.52e-07	9.69e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CAV1—prostate cancer	8.49e-07	9.66e-06	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—IL6—prostate cancer	8.35e-07	9.5e-06	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—NOS3—prostate cancer	8.32e-07	9.46e-06	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PTEN—prostate cancer	8.31e-07	9.46e-06	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—IL6—prostate cancer	8.17e-07	9.29e-06	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—EP300—prostate cancer	8.12e-07	9.24e-06	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—IL6—prostate cancer	7.99e-07	9.09e-06	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—EP300—prostate cancer	7.93e-07	9.02e-06	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PTEN—prostate cancer	7.84e-07	8.91e-06	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—PIK3CA—prostate cancer	7.77e-07	8.84e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CG—prostate cancer	7.74e-07	8.8e-06	CbGpPWpGaD
Propranolol—ADRB1—Signaling Pathways—AKT1—prostate cancer	7.71e-07	8.77e-06	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CB—prostate cancer	7.68e-07	8.74e-06	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PTGS2—prostate cancer	7.61e-07	8.66e-06	CbGpPWpGaD
Propranolol—ADRB2—Signaling Pathways—AKT1—prostate cancer	7.54e-07	8.57e-06	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—EP300—prostate cancer	7.47e-07	8.5e-06	CbGpPWpGaD
Propranolol—HTR1A—Signaling Pathways—AKT1—prostate cancer	7.37e-07	8.38e-06	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—PIK3CA—prostate cancer	7.34e-07	8.35e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—INS—prostate cancer	7.32e-07	8.33e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—CREBBP—prostate cancer	7.17e-07	8.16e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CD—prostate cancer	6.8e-07	7.73e-06	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PTEN—prostate cancer	6.64e-07	7.55e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—NOS3—prostate cancer	6.42e-07	7.3e-06	CbGpPWpGaD
Propranolol—CYP3A5—Metabolism—AKT1—prostate cancer	6.35e-07	7.22e-06	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—EP300—prostate cancer	6.33e-07	7.2e-06	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—PIK3CA—prostate cancer	6.01e-07	6.83e-06	CbGpPWpGaD
Propranolol—CYP1A1—Metabolism—AKT1—prostate cancer	6e-07	6.82e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CB—prostate cancer	5.93e-07	6.74e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PTGS2—prostate cancer	5.87e-07	6.68e-06	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—PIK3CA—prostate cancer	5.87e-07	6.67e-06	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—PIK3CA—prostate cancer	5.53e-07	6.29e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PTEN—prostate cancer	5.12e-07	5.83e-06	CbGpPWpGaD
Propranolol—CYP2C19—Metabolism—AKT1—prostate cancer	4.91e-07	5.58e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—EP300—prostate cancer	4.89e-07	5.56e-06	CbGpPWpGaD
Propranolol—ABCB1—Metabolism—AKT1—prostate cancer	4.79e-07	5.45e-06	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—PIK3CA—prostate cancer	4.68e-07	5.33e-06	CbGpPWpGaD
Propranolol—CYP2D6—Metabolism—AKT1—prostate cancer	4.52e-07	5.14e-06	CbGpPWpGaD
Propranolol—CYP1A2—Metabolism—AKT1—prostate cancer	3.83e-07	4.35e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—PIK3CA—prostate cancer	3.61e-07	4.11e-06	CbGpPWpGaD
Propranolol—CYP3A4—Metabolism—AKT1—prostate cancer	2.95e-07	3.36e-06	CbGpPWpGaD
